Abstract:Objective To improve the harmonization of lipid results and reduce the impact on clinical practice by using the unified calibration approach.Methods Sera from 400 inpatients in Zhongshan Hospital of Fudan University (March 13 2012 to March 19; age:37-68; 238 male; 162 female) were collected.Serum TC,TG,HDL-c,LDL-c,Apo A-Ⅰ and Apo B levels were measured by 5 different methods including Roche,Wako,Nittobo,DiaSys and Seikisui.Roche manufacturers were used as the reference method,and fresh samples were chosen as calibration serum to calibrate the five methods.The values of the calibration sera were similar to those of Roche calibrators.After being calibrated by calibration serum,we retested all samples and compared the results before and after calibration.Variation coefficient was used to describe the difference among the results of same sample that measured by each method before and after calibration.According to the concentrations of TG or LDL-c,we classified the samples into 4 or 5 groups and compared the results of each group,including different systems as well as before and after calibration.When TC values ≥6.22 mmol/L or LDL-c values ≥4.14 mmol/L was taken as the assessment criterion,we compared the influence of results from different systems on clinical treatment by calculating numbers of patients who need clinical treatment.Results The data showed that the harmonization was not well in different detection systems (CV 4.50％-10.46％),however,CV values could be reduced (2.82％-6.71％) after being calibrated by the calibration serum.There were significant difference among the groups (CV:LDL-c groups 4.03％-12.14％ ;TG groups 4.02％-18.42％),the CV values had no correlation with the LDL-c levels,while they raised with the increase of TG levels.In addition to the group that TG values ＞5.65 mmol/l,the CV values in other groups could be improved by calibration serum (CV:LDL-c groups 2.35％-6.91％ ;TG groups 2.08％-8.91％).Furthermore,the harmonization of the lipid and lipoprotein results would influence the clinical treatment.Conclusions The lipid and lipoprotein results of different detection systems were still significantly different.This may have an impact on clinical diagnosis and treatment.Using the same calibration serum to calibrate all systems could reduce the difference of results significantly and improve the harmonization of lipid as well as lipoprotein detection.TG high value had an impact on lipid and lipoprotein detection and could not be eliminated by calibration.

[Current Practices in the Harmonisation of Autoantibodies Test].

The Importance for the Correct Intended Use of Autoantibodies in Clinical Context

Quality Control of Autoantibody Detection in China

Summary of the 2012 national autoantibody testing quality control and comparison with the past 9 years

Summary of the 2011 national autoantibody testing quality control

Current State and Future Prospect of Autoimmunity Laboratory Diagnosis

The Analysis about the Quality Control of Autoantibody Detection in Shanghai

Autoantibodies - enemies, and/or potential allies?

Using Bland-Altman plot-based harmonization algorithm to optimize the harmonization for immunoassays

Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective

Autoantibody profiling of Chinese patients with autoimmune hepatitis using immunoproteomic analysis.

Detection of antinuclear antibodies: recommendations from EFLM, EASI and ICAP

Analysis of Clinical Application of ENA Polypeptide Autoantibody Profile Detection Using Immunoblotting Technique

Investigating the Current Harmonization Status of Tumor Markers Using Global External Quality Assessment Programs: A Feasibility Study

Harmonization of lipid results and influence on clinical diagnosis

Detection of Autoantibodies in Chronic Liver Disease and Its Correlation with Autoimmune Liver Diseases

From autoantibody test results to decision making: Incorporating likelihood ratios within medical practice

Neutralizing Antibody Validation Testing and Reporting Harmonization

Cutting edge confusion about cut-off settings in autoimmune diagnostics

Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy

Clinical Performance of the Line Immunoassay and Digital Liquid Chip Method for Detecting Autoimmune Liver Disease Autoantibodies